Concept:
Hyperekplexia (startle disease stiff-baby syndrome) is a rare, non-epileptic neurogenetic disorder characterized by exaggerated, non-habituating startle responses to tactile, auditory, or visual stimuli, and generalized neonatal hypertonia.
Explanation:
• Hyperekplexia is most commonly inherited in an autosomal dominant or recessive pattern due to mutations in the GLRA1 gene (encoding the alpha-1 subunit of the inhibitory glycine receptor), or less commonly GLRB or SLC6A5.
• Impaired glycinergic inhibitory neurotransmission in the brainstem and spinal cord leads to uninhibited motor startle reflexes and persistent muscular rigidity that diminishes during sleep.
• The hallmark presentation is marked neonatal stiffness, exaggerated startle response to sudden unexpected sensory stimuli (tapping the nose, tactile taps, auditory or visual stimuli), and episodic life-threatening apnea or tonic spasms.
• Because these paroxysmal episodes are non-epileptic in origin, the interictal and ictal EEG is completely normal, and standard antiepileptic drugs (e.g., phenobarbital, phenytoin) are entirely ineffective.
• Tapping the tip of the nose elicits an exaggerated startle reflex with non-habituating head retraction (pathognomonic clinical test).
• The therapeutic drug of choice is Clonazepam (a GABA-A receptor agonist that enhances inhibitory tone), and acute hypertonia-induced apnea is relieved by the Vigevano maneuver (forced head-to-knees flexion).
Final Answer:
The clinical features of neonatal stiffness, exaggerated stimulus-induced startle responses, a normal EEG, and non-responsiveness to anticonvulsants are diagnostic of Hyperekplexia.